ESOVYND Trademark

Trademark Overview

On Thursday, January 21, 2021, a trademark application was filed for ESOVYND with the United States Patent and Trademark Office. The USPTO has given the ESOVYND trademark a serial number of 90479748. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The ESOVYND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
esovynd

General Information

Serial Number90479748
Word MarkESOVYND
Filing DateThursday, January 21, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
Translation of Words in MarkThe wording “ESOVYND” has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIngelheim 55218
DE

Trademark Events

Event DateEvent Description
Thursday, April 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 25, 2021NEW APPLICATION ENTERED
Friday, May 21, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 18, 2021ASSIGNED TO EXAMINER
Friday, May 21, 2021NON-FINAL ACTION E-MAILED
Friday, May 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 15, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, October 15, 2021EXAMINER'S AMENDMENT ENTERED
Friday, October 15, 2021EXAMINERS AMENDMENT E-MAILED
Friday, October 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 4, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 4, 2022SOU EXTENSION 1 FILED
Friday, March 4, 2022SOU EXTENSION 1 GRANTED
Monday, January 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2023SOU EXTENSION 2 FILED
Monday, January 9, 2023SOU EXTENSION 2 GRANTED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 3 FILED
Thursday, December 28, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 28, 2023SOU EXTENSION 4 FILED
Thursday, December 28, 2023SOU EXTENSION 4 GRANTED
Saturday, December 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023SOU EXTENSION 3 GRANTED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

esovynd system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary